6:10 PM
 | 
Sep 12, 2012
 |  BC Extra  |  Financial News

Pluristem proposes follow-on

Pluristem Therapeutics Inc. (NASDAQ:PSTI; Tel Aviv:PSTI) said late Wednesday it is planning a follow-on underwritten...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >